Sze Jun Hui, Brownlie Jeremy C, Love Christopher A
School of Natural Sciences, Griffith University, Nathan, QLD, 4111, Australia.
Environmental Futures Research Institute, Griffith University, Nathan, QLD, 4111, Australia.
3 Biotech. 2016 Jun;6(1):67. doi: 10.1007/s13205-016-0379-9. Epub 2016 Feb 15.
Hyaluronic acid (HA) is a polysaccharide found in the extracellular matrix of vertebrate epithelial, neural and connective tissues. Due to the high moisture retention, biocompatibility and viscoelasticity properties of this polymer, HA has become an important component of major pharmaceutical, biomedical and cosmetic products with high commercial value worldwide. Currently, large scale production of HA involves extraction from animal tissues as well as the use of bacterial expression systems in Streptococci. However, due to concerns over safety, alternative sources of HA have been pursued which include the use of endotoxin-free microorganisms such as Bacilli and Escherichia coli. In this review, we explore current knowledge of biosynthetic enzymes that produce HA, how these systems have been used commercially to produce HA and how the challenges of producing HA cheaply and safely are being addressed.
透明质酸(HA)是一种存在于脊椎动物上皮组织、神经组织和结缔组织细胞外基质中的多糖。由于这种聚合物具有高保湿性、生物相容性和粘弹性,HA已成为全球具有高商业价值的主要药品、生物医学产品和化妆品的重要成分。目前,HA的大规模生产涉及从动物组织中提取以及在链球菌中使用细菌表达系统。然而,出于对安全性的担忧,人们一直在寻找HA的替代来源,包括使用无内毒素的微生物,如芽孢杆菌和大肠杆菌。在这篇综述中,我们探讨了目前关于产生HA的生物合成酶的知识,这些系统如何在商业上用于生产HA,以及如何应对廉价且安全地生产HA的挑战。